How to Get GLP-1 Patients as a Psychiatrist in Florida

You’ve seen it in your own practice: patients frustrated by weight gain from psych meds, asking about ‘that Ozempic everyone’s talking about.’ Maybe you’ve already prescribed it a few times and wondered if there’s a real opportunity here. Here’s the reality: there is. And it’s massive.

By 2025, an estimated 6% of Americans—roughly 20 million people—were actively taking GLP-1 medications like semaglutide (Ozempic/Wegovy) or tirzepatide. That’s a 600% increase in weight-loss usage over just six years. Demand is exploding, and most patients can’t find providers to help them. Meanwhile, you’re already managing chronic conditions, behavioral change, and medication side effects—exactly the skills GLP-1 patients need.

The question isn’t whether psychiatrists should offer GLP-1 services. It’s how to do it without adding unsustainable workload to an already full plate.

This guide breaks down the business case, the clinical workflow, and the state-by-state regulations so you can make an informed decision about adding weight management to your practice—or scaling it intelligently if you’ve already started.

Why Psychiatrists Are Uniquely Positioned for GLP-1 Care

The Patient Overlap You’re Already Seeing

Nearly half of psychiatrists surveyed in late 2023 were already prescribing or recommending Ozempic or similar weight-loss drugs—often to address medication-induced weight gain or comorbid obesity. If you’ve been treating patients on antipsychotics, mood stabilizers, or certain antidepressants, you know weight gain is one of the most common reasons patients stop their meds. Offering GLP-1 therapy gives you a tool to address this barrier while keeping patients stable on necessary psychiatric treatment.

Beyond medication side effects, many psychiatric patients struggle with binge eating disorder, emotional overeating, or obesity linked to depression and anxiety. Unlike a traditional weight-loss clinic, you bring expertise in behavior change and mental health—critical for sustaining motivation and managing any mood effects during weight loss. You’re not just prescribing a drug; you’re treating the whole person.

A Market Gap You Can Fill

The U.S. has roughly 75% of adults who are overweight or obese, but a severe shortage of obesity medicine specialists. Tens of thousands of new patients start GLP-1 treatments weekly, and many can’t access care because there aren’t enough providers. Primary care doctors are overwhelmed. Endocrinologists are booked months out. Telehealth obesity clinics are scaling rapidly but often lack the psychiatric insight your patients need.

This creates an opening: psychiatrists who offer GLP-1 care can differentiate themselves by combining weight management with mental health support. Patients increasingly want integrated care—someone who understands that their weight, mood, and medication side effects are interconnected.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

The Economics: How to Acquire Patients Without Gambling Thousands on Marketing

Let’s talk money. If you try to build a GLP-1 patient base from scratch using traditional marketing, here’s what you’re up against:

• SEO takes 6-12 months of consistent investment (content, backlinks, technical optimization) before generating meaningful traffic. Most solo providers don’t have the expertise or patience.
• Google Ads for mental health and weight-loss keywords cost $15-40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+, and you’ll spend thousands testing campaigns before finding what works.
• Directory listings like Psychology Today or Zocdoc charge monthly fees ($100-300+) and you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35-100+), so total monthly cost adds up fast.
• Agency/consultant fees for managing campaigns can run $2,000-5,000/month, plus ad spend.

When you factor in all costs—agency fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads, months of testing—acquiring a qualified psychiatric patient through DIY marketing typically costs $200-500+ each. And that’s if you know what you’re doing. Most providers burn through $3,000-5,000/month for months before seeing ROI.

The Klarity Health Model: Pay Only When You See Patients

This is where platforms like Klarity Health change the game. Instead of gambling on marketing channels with uncertain results, Klarity uses a pay-per-appointment model. You pay a standard listing fee per new patient lead—only when a qualified patient books with you. No upfront marketing spend. No monthly subscription fees. No wasted ad spend on clicks that don’t convert.

Here’s what you get:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule—only pay when you actually see patients

Frame it this way: instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient shows up. That’s guaranteed ROI vs. gambling on marketing channels. For most providers—especially those starting out or scaling—a platform that handles patient acquisition removes the risk entirely.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience to wait 6-12 months for results. But for most psychiatrists, the opportunity cost of that time and money is too high.

How to Get GLP-1 Patients: Practical Strategies

1. Start With Your Existing Practice

The easiest path to GLP-1 patients is identifying current patients who meet criteria (BMI ≥30 or ≥27 with comorbidities like hypertension or diabetes). During medication reviews, bring up weight management—especially if the patient has gained weight on psych meds. Many will welcome the conversation. You’re not cold-calling; you’re offering a solution to a problem they’ve already mentioned.

This ‘no additional marketing’ approach is efficient and builds on established trust. You can convert 5-10 existing patients immediately just by offering the service.

2. Join a Telehealth Platform

Platforms like Klarity, Ro, or Hims already invest heavily in advertising and funnel patient inquiries to enrolled providers. This is the fastest way to access high patient volume without building your own marketing infrastructure.

Look for platforms that:

• Pre-screen patients for medical eligibility
• Handle scheduling and payment processing
• Provide telehealth infrastructure
• Offer both insurance and cash-pay options
• Don’t require exclusivity (so you can maintain your existing practice)

WeightWatchers acquired a telehealth provider in 2023 to handle the influx of members seeking GLP-1 medications—a signal that telehealth is becoming the dominant channel for these services.

3. Market Independently (If You Have the Bandwidth)

If you want to build your own brand, focus on:

• SEO: Create content about ‘GLP-1 and mental health,’ ‘weight loss for psychiatric patients,’ ‘managing medication weight gain.’ This is a long game (6-12 months) but can generate consistent leads.
• Social media: Share patient success stories (with permission), educate about obesity’s impact on mental health, and position yourself as the psychiatrist who treats the whole person.
• Local referrals: Let primary care doctors, endocrinologists, and therapists know you offer this service. Emphasize you’ll update them and refer patients back for routine care.

4. Emphasize Your Unique Value

Generic weight-loss clinics can’t match your expertise in:

• Managing mood changes during weight loss
• Addressing binge eating disorder and emotional overeating
• Adjusting psychiatric medications as weight changes
• Providing ongoing behavioral support beyond ‘eat less, move more’

Position yourself as ‘Psychiatrist offering medical weight management’—not just another GLP-1 prescriber.

GLP-1 Telehealth: What You Need to Know

Licensure & Scope of Practice

You must be licensed in the patient’s state. Psychiatrists (MD/DO) hold full prescriptive authority for GLP-1 medications in all states. Psychiatric NPs (PMHNPs) and PAs need to navigate state-specific scope rules:

• California: NPs can become independent ‘104 NPs’ starting in 2026 after 3 years supervised practice. Until then, they need physician oversight. California requires patient consent for telehealth (verbal or written, documented in chart).

• Texas: Strict collaboration state. NPs and PAs must have a Prescriptive Authority Agreement with a Texas physician. Texas is in the Interstate Medical Licensure Compact (IMLC), which expedites physician licensure. No in-person visit required for telehealth if standard of care is met via synchronous video.

• Florida: Out-of-state physicians can register as Florida telehealth providers without full licensure. Florida NPs need physician supervision (autonomous practice is limited to primary care NPs only). No in-person exam required for non-controlled substances via telehealth.

• New York: NPs with ≥3,600 hours of practice can operate without physician collaboration. New York is not in IMLC—out-of-state psychiatrists need full NY license. Strong telehealth parity laws make virtual care attractive.

• Pennsylvania: All NPs require physician collaborative agreements (no independent practice). Pennsylvania is in IMLC (for physicians) and joined the Nurse Licensure Compact in 2025. Telehealth allowed with no in-person requirement for non-controlled substances.

• Illinois: NPs can achieve Full Practice Authority (FPA) after 4,000 hours of practice and 250 hours additional education. FPA-NPs can prescribe independently. Illinois is in IMLC and has strong telehealth parity laws.

Prescribing Standards & Compliance

GLP-1 agonists are not controlled substances, so the Ryan Haight Act’s in-person exam requirement does not apply. You can legally prescribe semaglutide via telehealth across state lines if licensed in the patient’s state.

Standard of care requirements:

• Comprehensive video evaluation (medical history, BMI, comorbidities)
• Baseline labs (A1c, fasting glucose, liver enzymes, TSH if indicated)
• Rule out contraindications (medullary thyroid cancer history, pancreatitis)
• Informed consent for off-label use (if using Ozempic vs. Wegovy)
• Monthly follow-ups during dose titration
• Monitoring for side effects (GI upset, mood changes)

Psychiatric considerations: The FDA reviewed reports of suicidal ideation linked to GLP-1s in 2023 but found no clear causal link and directed removal of suicide warnings from labels by early 2026. Still, as a psychiatrist, you should proactively ask about mood changes during check-ins—this is a value-add competitors can’t match.

Cash-Pay vs. Insurance

Reality check: Most insurers cover GLP-1 drugs for diabetes, but coverage for obesity is limited. As of mid-2024, only 13 state Medicaid programs (including CA, PA, and IL) covered GLP-1s for weight loss. Many private plans exclude them entirely.

This creates two paths:

Cash-Pay Model (Most Common):

• Patients pay directly for consults (per visit or monthly subscription)
• No prior authorizations, no insurance denials
• Pairs well with patients already paying cash for medications
• Brand-name Wegovy costs $1,300+ monthly without insurance; compounded semaglutide runs $200-400/month

Insurance Model:

• Bill standard E/M codes or Medicare G0447 (behavioral counseling for obesity)
• Wider patient access, especially for those who can only afford treatment if visits are covered
• Extensive documentation required
• Prior authorizations for medications can be time-consuming
• Medicare announced plans in late 2025 to pilot covering weight-loss drugs—this may shift the landscape

Hybrid Approach (Recommended): Charge cash for initial consult (lengthy evaluation not fully reimbursed by insurance), then bill insurance for follow-ups if patient has coverage. Be transparent about what’s self-pay vs. billed.

Scaling Without Burnout: Workflow Design & Self-Care

The biggest risk when adding GLP-1 services isn’t clinical—it’s operational overload. Here’s how to scale intelligently:

Streamline Intake & Documentation

Digital intake forms: Gather comprehensive history (weight history, diet, medical conditions, mental health status) before the first consult. This saves 10-15 minutes per appointment and ensures you don’t miss contraindications.

Standardized order sets: Create an ‘Obesity Intake Panel’ of labs that can be ordered with one click. Develop inclusion/exclusion criteria and clinical checklists to ensure every initial consult covers nutrition, exercise, goal-setting, medication teaching, and mental health screening.

Template documentation: Use smart phrases or macros for common scenarios (dose titration, side effect management, patient education). This maintains quality while cutting charting time in half.

Optimize Follow-Up Cadence

GLP-1 patients typically need monthly follow-ups for the first 3-6 months during dose escalation. For a busy psychiatrist, this can be overwhelming. Solutions:

Alternate providers: An MD/NP sees the patient at months 1 and 3; a nutritionist or health coach conducts check-ins at months 2 and 4. Any issues get escalated back to the prescriber.

Group telehealth sessions: A weekly 30-minute group Zoom led by a behavioral health specialist or dietitian can educate and motivate multiple patients at once, reducing repetitive one-on-one counseling.

Delegate non-specialist tasks: Medical assistants or RNs can gather interim data (weights, BP, symptom questionnaires) ahead of visits and handle routine patient questions via portal messaging. You focus on medication decisions and complex counseling, not dietary minutiae.

Leverage Technology

Remote monitoring: Issue connected scales or ask patients to report weekly weights via app. You can track progress at a glance and intervene only if needed—shortening follow-up visits to 10-15 minutes.

Automated workflows: Appointment reminders, online scheduling, and AI-driven chatbots for FAQs (e.g., ‘Is nausea normal on this dose?’) reduce manual work.

Asynchronous check-ins: Once patients are stable on a GLP-1 dose, visits can be spaced to every 2-3 months with brief virtual check-ins or asynchronous updates (patients message weight/symptoms, you respond within 24 hours).

Set Boundaries to Protect Your Time

Calibrate patient load gradually: Start with a few half-days per week dedicated to weight clients, rather than mixing them into every open slot. This prevents overextension and allows time to adjust workflows.

Maintain practice balance: Many psychiatrists keep a mix of psychiatric and weight-management patients to add variety and maintain skills in both areas. Others fully transition to obesity medicine. Either way, schedule regular breaks, vacations, and admin time.

Firm availability hours: Telehealth can blur work-life lines. Set firm hours for patient communication and use delayed email replies or an answering service for after-hours.

Hire support staff: Investing in a part-time NP/PA to share the load or a health coach to handle lifestyle counseling may seem costly, but it pays off in sustainability. You can handle a large panel without feeling overwhelmed.

Monitor Your Own Burnout Risk

Signs of burnout—emotional exhaustion, depersonalization, declining performance—should prompt a reassessment of workload. Research shows that greater schedule control and virtual practice options can mitigate provider burnout. If you’re feeling stretched, temporarily cap new patient intakes or scale up support staff.

Team-based care model: A lead psychiatrist supervises PMHNPs who handle routine follow-ups, while the psychiatrist focuses on initial evaluations and complex cases. This mirrors how many psychiatric clinics operate and can be extended to weight-loss services.

State-by-State Regulatory Quick Reference

The Bottom Line: Is This Worth It?

Adding GLP-1 services to your psychiatry practice is worth it if:

1. You’re interested in treating the whole person—not just prescribing meds but helping patients improve physical health, confidence, and quality of life.

2. You’re willing to invest in workflow optimization—this isn’t just adding one more thing to your plate; it’s designing a sustainable service line.

3. You recognize the economic opportunity—whether through a platform like Klarity or building your own patient base, GLP-1 care can generate significant additional revenue without the gambling on expensive marketing channels.

4. You value your own well-being—scaling intelligently with support staff, technology, and clear boundaries means you can grow impact without burning out.

Patient demand is real. The market gap is real. And psychiatrists bring unique expertise that no generic weight-loss clinic can match. The question is whether you’re ready to step into this space—and do it in a way that’s clinically sound, financially sustainable, and personally rewarding.

Frequently Asked Questions

Can I prescribe GLP-1 medications via telehealth without seeing the patient in person?

Yes. GLP-1 medications are not controlled substances, so the Ryan Haight Act’s in-person exam requirement does not apply. You must be licensed in the patient’s state and meet that state’s standard of care for telehealth (typically a thorough video evaluation, informed consent, and appropriate documentation).

Do I need special certification to prescribe GLP-1s for weight loss?

No special certification is required. Psychiatrists (MD/DO) can prescribe within their scope of practice. However, pursuing obesity medicine CME or certification (e.g., ABOM) can improve clinical confidence and may enhance marketing.

What if my state requires NP/PA collaboration?

If you’re a psychiatric NP in a state requiring physician collaboration (Texas, Pennsylvania, Florida for psych NPs), you’ll need a formal agreement with a supervising physician. Many telehealth platforms pair NPs with supervising MDs, or you can partner with a local psychiatrist.

How much can I realistically earn from GLP-1 services?

Revenue depends on patient volume and pricing model. Cash-pay initial consults typically run $150-300; follow-ups $75-150. If you see 10 new GLP-1 patients monthly and maintain a panel of 50 ongoing patients (averaging $100/visit monthly), that’s $6,500/month or ~$78,000/year in additional revenue. Platform fees or staff costs will reduce net, but margins remain attractive.

What about liability—am I at risk prescribing outside my specialty?

Obesity is a chronic disease, and prescribing medications for it falls within general physician practice. Psychiatrists already manage chronic conditions and medication side effects. Ensure your malpractice insurance covers weight-loss prescribing (inform your insurer). Following standard of care (appropriate evaluation, informed consent, monitoring) minimizes liability risk.

How do I handle patients who want GLP-1s for vanity, not health?

Set clear clinical criteria (BMI ≥30 or ≥27 with comorbidities). Educate patients that GLP-1s are tools to improve health, not cosmetic quick fixes. Patients who don’t meet criteria can be referred to traditional weight-loss programs or nutritionists. This messaging attracts motivated patients who value medical guidance.

Ready to Get Started?

If you’re a psychiatrist looking to expand your practice with high-demand GLP-1 services—without the risk of gambling thousands on unproven marketing—platforms like Klarity Health offer a turnkey solution. You get pre-qualified patients, built-in telehealth infrastructure, and you only pay when you see patients. No upfront costs. No monthly subscriptions. Just guaranteed ROI.

Explore Klarity’s provider network to see how other psychiatrists are scaling GLP-1 practices without burning out—or contact us to discuss how we can support your growth.

Citations

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage). Published May 27, 2025. Available at: www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’. Published October 20, 2025. Available at: www.confectionerynews.com

3. Time Magazine – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’. Published August 22, 2025. Available at: time.com

4. Axios – ‘America’s doctors need more obesity medicine training’. Published May 28, 2024. Available at: www.axios.com

5. Axios – ‘States slow to cover GLP-1s for weight loss’ (KFF policy report). Published November 5, 2024. Available at: www.axios.com

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is